Suzanne Randle

Suzanne Randle is currently the Associate Director in Oncology Safety Science at AstraZeneca, where they focus on drug discovery and development, particularly regarding bone marrow toxicity. With extensive experience in cell biology spanning basic biology and disease investigations, they have also managed the Cambridge Alliance on Medicines Safety, fostering collaboration across industry and academia. Suzanne previously worked as a Senior Scientist at AstraZeneca and held postdoctoral researcher positions at the University of Cambridge and the Cambridge Institute for Medical Research. They earned a PhD in Cell/Cellular and Molecular Biology from the University of Cambridge and a BS in Biomedical Sciences from The University of Manchester.